» Articles » PMID: 28239370

Expression Is Associated with Pathogenicity

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2017 Feb 28
PMID 28239370
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

CapB2 is recognized as a tyrosine kinase and is likely a vital factor in extracellular polysaccharide synthesis in , but its pathogenicity function and regulatory mechanism remain obscure. Here, we demonstrate that CapB2 enhances bacterial virulence in a murine model. Mice infected with the wild type SA75 strain exhibited significantly larger ( < 0.05) skin lesions from days 4 to 7 of infection than those challenged with the mutant strain. The effect on virulence was reverted by restoring the mutation to the wild type. The related components of the wild type SA75 cell wall in the mutant strain (SA75Δ) were thinner than wild type SA75 strain and the mutant complemented strain (SA75Δ-C), which was determined by the transmission electron microscopy. The survival percentages of the wild type strain SA75 and SA75Δ-C were significantly higher relative to SA75Δ. The results of qRT-PCR studies also indicated that mutations in regulatory gene led to a drastic increase in capB2 gene transcription, with a 326-fold increase of growth at 6 h compared with the wild type strain, suggesting that sarA is a major negative regulator of capB2 expression. Taken together, these results demonstrate that the expression of CapB2 promotes virulence in a mouse model of skin infection, and that gene transcription is regulated negatively by SarA.

Citing Articles

Heterogeneous Vancomycin-Intermediate Uses the VraSR Regulatory System to Modulate Autophagy for Increased Intracellular Survival in Macrophage-Like Cell Line RAW264.7.

Dai Y, Gao C, Chen L, Chang W, Yu W, Ma X Front Microbiol. 2019; 10:1222.

PMID: 31214151 PMC: 6554704. DOI: 10.3389/fmicb.2019.01222.

References
1.
Olivares-Illana V, Meyer P, Bechet E, Gueguen-Chaignon V, Soulat D, Lazereg-Riquier S . Structural basis for the regulation mechanism of the tyrosine kinase CapB from Staphylococcus aureus. PLoS Biol. 2008; 6(6):e143. PMC: 2422856. DOI: 10.1371/journal.pbio.0060143. View

2.
Nanra J, Buitrago S, Crawford S, Ng J, Fink P, Hawkins J . Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother. 2012; 9(3):480-7. PMC: 3891703. DOI: 10.4161/hv.23223. View

3.
Luong T, Ouyang S, Bush K, Lee C . Type 1 capsule genes of Staphylococcus aureus are carried in a staphylococcal cassette chromosome genetic element. J Bacteriol. 2002; 184(13):3623-9. PMC: 135137. DOI: 10.1128/JB.184.13.3623-3629.2002. View

4.
Luong T, Newell S, Lee C . Mgr, a novel global regulator in Staphylococcus aureus. J Bacteriol. 2003; 185(13):3703-10. PMC: 161569. DOI: 10.1128/JB.185.13.3703-3710.2003. View

5.
Zhao L, Xue T, Shang F, Sun H, Sun B . Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. Infect Immun. 2010; 78(8):3506-15. PMC: 2916273. DOI: 10.1128/IAI.00131-10. View